1. This month in Gastroenterology
Eugene B. Chang, Laura Harrell 
Gastroenterology 
Volume 128, Issue 3, Pages (March 2005)
DOI: /j.gastro
Copyright © 2005 American Gastroenterological Association Terms and Conditions

2. Figure 1
(A) The effects of placebo, Lactobacillus, and Bifidobacterium on a composite score of IBS symptoms. Score derived from the sum of scores for abdominal pain/discomfort, bloating/distention, and bowel movement difficulty. Note significant reduction in composite scores throughout treatment period and into wash-out phase for subjects treated with Bifidobacterium but not with lactobacillus or placebo. (*P < .05 vs placebo; all comparisons adjusted for any differences in baseline symptom score). (B) Comparison of peripheral blood mononuclear cells IL-10:IL-12 ratios, at baseline and following therapy with either placebo, Lactobacillus, or Bifidobacterium with that of a normal control period. Note abnormal baseline ration in IBS subjects with a normalization of this ratio following the administration of Bifidobacterium alone.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

3. Figure 2 (A) Pre-HSCT and (B) post-HSCT colonoscopic findings.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

4. Figure 3
(A) Example of a spontaneous reflux event, as evidenced by a drop in esophageal pH and in intraluminal impedance, that occurred during a period of absent basal lower esophageal sphincter (LES) pressure. The reflux event is followed by a simultaneous esophageal pressure wave response. (B) Example of cough-induced reflux provoked by suctioning of the endotracheal tube.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

5. Figure 4
(A) Inhibition of MCT1 abundance by RNA interference using 21-nt siRNAs targeted to the MCT1 transcript. Representative immunofluorescence images showing MCT1 abundance within the plasma membrane 72 hours posttransfection; (i) mock-transfection, (ii) MCT1 specific siRNA, and (iii) unrelated siRNA control. (B) Western analysis at increasing times (36–96 hours) posttransfection. Con, unrelated siRNA control; 0, mock-transfected control. (C) Butyrate modulation of target gene expression in HT-29 cells. Cells were either treated with NaBut (0.2–10 mmol/L) for 36 hours or left untreated for the same time period. Total RNA was isolated and abundance of IAP, p21, CD1, bcl-xL, and bak mRNA determined by Northern blotting. Data shown are representative of 3 independent experiments. β-actin served as an internal loading control.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions